Lailing M Ku from 3460 Virgil Cir, Pleasanton, CA 94588, age 76, Phone: 9254626618

Neisseria Gonorrhoeae Specific Oligonucleotide Sequences
view source
US Patent:

20080090240, Apr 17, 2008
Filed:

Apr 6, 2007
Appl. No.:

11/784502
Inventors:

Lailing Ku - Pleasanton CA, US
Charlene Bush-Donovan - Livermore CA, US
David Sherman - Davis CA, US
Qi Meng - Fremont CA, US
International Classification:

C07H 21/04
C12Q 1/68
US Classification:

435006000, 536022100
Abstract:

The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the selective and specific detection of in biological samples. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the detection and diagnosis of gonococcal infection. The inventive oligonucleotide primers and probes can also be used in combination with other specific oligonucleotide primers and probe for the simultaneous detection of and other target organisms, such as

Reagents And Methods For Detecting Cyp2C9 Polymorphisms
view source
US Patent:

20100047800, Feb 25, 2010
Filed:

Jan 22, 2008
Appl. No.:

12/523000
Inventors:

Minxue Zheng - Foster City CA, US
Lailing Ku - Pleasanton CA, US
Lu-ping Shen - San Leandro CA, US
Carrie Wong - San Francisco CA, US
Charlene Bush-Donovan - Livermore CA, US
Assignee:

SIEMENS HEALTHCARE DIAGNOSTICS INC. - Tarrytown NY
International Classification:

C12Q 1/68
C12P 19/34
C07H 21/04
US Classification:

435 6, 435 912, 536 231, 536 243, 536 2433
Abstract:

The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the specific detection of clinically relevant CYP2C9 polymorphisms, in particular CYP2C9 polymorphisms associated with adverse drug response. The oligonucleotide sequences are also provided assembled as kits that can be used to predict how an individual will respond to drugs or other xenobiotic compounds that are metabolized, at least in part, by CYP2C9.

Reagents And Methods For Detecting Cyp2D6 Polymorphisms
view source
US Patent:

20100105041, Apr 29, 2010
Filed:

Dec 14, 2007
Appl. No.:

12/518697
Inventors:

Lailing Ku - Pleasanton CA, US
Charlene Bush-Donovan - Livermore CA, US
Lu-ping Shen - San Leandro CA, US
Assignee:

SIEMENS HEALTHCARE DIAGNOSTICS INC. - Tarrytown NY
International Classification:

C12Q 1/68
C07H 21/04
US Classification:

435 6, 536 231, 536 2433, 536 243
Abstract:

The present invention relates to oligonucleotide sequences for amplification primers and detection probes and their use in nucleic acid amplification methods for the specific detection of clinically relevant CYP2D6 polymorphisms, in particular CYP2D6 polymorphisms associated with adverse drug response. The oligonucleotide sequences are also provided assembled as kits that can be used to predict how an individual will respond to drugs or other xenobiotic compounds that are metabolized, at least in part, by CYP2D6.

Chlamydia Trachomatis Specific Oligonucleotide Sequences
view source
US Patent:

20100248220, Sep 30, 2010
Filed:

Nov 7, 2006
Appl. No.:

12/090269
Inventors:

Lailing Ku - Pleasanton CA, US
Charlene Bush-Donovan - Livermore CA, US
David Sheman - Davis CA, US
Qi Meng - Fremont CA, US
Assignee:

SIEMENS HEALTHCARE DIAGNOSTICS INC. - Tarrytown NY
International Classification:

C12Q 1/68
C07H 21/04
US Classification:

435 6, 536 237, 536 2433
Abstract:

The present invention relates to oligonucleotide sequences for amplification primers and detection probes and to their use in nucleic acid amplification methods for the selective and specific detection of in biological samples. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the detection and diagnosis of chlamydial infection. The inventive oligonucleotide primers and probes can also be used in combination with other specific oligonucleotide primers and probes for the simultaneous detection of and other target organisms, such as

Hepatitis B Virus (Hbv) Specific Oligonucleotide Sequences
view source
US Patent:

20100255482, Oct 7, 2010
Filed:

Oct 29, 2008
Appl. No.:

12/741062
Inventors:

Lu-ping Shen - San Leandro CA, US
Carrie Li Wong - San Francisco CA, US
Lailing Ku - Pleasanton CA, US
Andy Ying - Fremont CA, US
Charlene Bush-Donovan - Livermore CA, US
Assignee:

SIEMENS HEALTHCARE DIAGNOSTICS INC. - Tarrytown NY
International Classification:

C12Q 1/68
C07H 21/04
US Classification:

435 6, 536 231, 536 243
Abstract:

The present invention relates to oligonucleotide sequences for amplification primers and detection probes and to their use in nucleic acid amplification methods for the detection of HBV in biological samples. In particular, oligonucleotide sequences are provided for the sensitive qualitative or quantitative detection of all eight HBV genotypes. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the diagnosis of HBV infection.